Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising geriatric population
3.2.1.2 Increasing prevalence of chronic disorders and lifestyle diseases
3.2.1.3 Growing adoption of point of care testing devices
3.2.1.4 Increasing demand for laboratory automation
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of instruments
3.2.2.2 Requirement for high capital investment
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Product, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Reagents
5.2.1 Buffers
5.2.2 Calibrators
5.2.3 Controls
5.2.4 Standards
5.2.5 Other reagents
5.3 Analyzers
5.3.1 By technology
5.3.1.1 Semi-automatic analyzers
5.3.1.2 Fully automatic analyzers
5.3.1.3 Point of care analyzers
5.3.2 By type
5.3.2.1 Benchtop analyzers
5.3.2.2 Floor-standing analyzers
5.4 Other products
Chapter 6 Market Estimates and Forecast, By Test Type, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Basic metabolic panel
6.3 Liver panel
6.4 Renal profile
6.5 Lipid profile
6.6 Thyroid function panel
6.7 Electrolyte panel
6.8 Speciality chemical tests
Chapter 7 Market Estimates and Forecast, By Modality, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Centralized
7.3 Decentralized
Chapter 8 Market Estimates and Forecast, By End-use, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals and clinics
8.3 Specialty clinics
8.4 Diagnostic laboratories
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.2 Danaher Corporation
10.3 EKF Diagnostics
10.4 F.Hoffmann-La Roche Ltd.
10.5 Hitachi Ltd.
10.6 HORIBA Ltd.
10.7 Ortho Clinical Diagnostics
10.8 QuidelOrtho Corporation
10.9 Siemens Healthineers AG
10.10 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
10.11 Sysmex Corporation
10.12 Thermo Fisher Scientific Inc.
